Adage Capital Partners
OKUR

Adage Capital Partners’s OnKure Therapeutics OKUR Stock Holding History

Adage Capital Partners’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.99M Buy
+1,204,819
New +$3.72M 0.01% 774
2023
Q4 		– Sell
-6,500
Closed -$495K – 941
2023
Q3 		$495K Buy
+6,500
New +$442K ﹤0.01% 782

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Adage Capital Partners's OKUR Position: Q1 2026 in Review

Adage Capital Partners opened a new position in OnKure Therapeutics (OKUR) in Q1 2026: 1,204,819 shares worth $4.99M. The stake represents 0.01% of the portfolio and ranks #774 among its holdings. This is a return to the name: Adage Capital Partners previously reported a position in OKUR as recently as Q3 2023.

Adage Capital Partners first reported a position in OKUR in Q3 2023 and has held it in 2 quarters since. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

  • Adage Capital Partners held 1,204,819 shares of OnKure Therapeutics worth $4.99M as of Q1 2026.
  • OnKure Therapeutics was a new Adage Capital Partners position in Q1 2026.
  • OnKure Therapeutics made up 0.01% of Adage Capital Partners's portfolio in Q1 2026, its #774 holding.
  • Adage Capital Partners first reported a position in OnKure Therapeutics in Q3 2023 and has held it in 2 quarters since.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.